Nordén G, Björck S, Granerus G, Nyberg G
Nephron. 1987;47(1):36-42. doi: 10.1159/000184454.
Plasma as well as renal clearance of 51Cr-EDTA, serum creatinine, plasma beta-2-microglobulin and endogenous creatinine clearance were compared and evaluated in patients with diabetic nephropathy and in control patients with renal disease of other origin. The difference between the plasma clearance and the renal clearance of 51Cr-EDTA, that is the extrarenal clearance, was found to be higher in diabetics than in control patients (7.0 vs. 3.5 ml/min; p less than 0.001). The serum creatinine correlated well with the glomerular filtration rate (GFR), but in the individual case the GFR was not at all predictable from serum creatinine. The plasma beta-2-microglobulin did not correlate better than serum creatinine to 51Cr-EDTA clearance, and did not permit an earlier diagnosis of renal insufficiency. Endogenous creatinine clearance overestimated GFR by 0-180%. Due to residual urine, the coefficient of variation was higher in diabetic patients than in controls, but the effect of this imperfection was reduced by using multiple collection periods. In conclusion, the renal clearance of 51Cr-EDTA was found to be preferable to the other methods.
对糖尿病肾病患者和其他病因所致肾病的对照患者,比较并评估了51Cr-乙二胺四乙酸(51Cr-EDTA)的血浆清除率及肾脏清除率、血清肌酐、血浆β2-微球蛋白和内生肌酐清除率。发现糖尿病患者51Cr-EDTA的血浆清除率与肾脏清除率之差,即肾外清除率,高于对照患者(7.0对3.5 ml/分钟;p<0.001)。血清肌酐与肾小球滤过率(GFR)相关性良好,但在个体病例中,无法根据血清肌酐预测GFR。血浆β2-微球蛋白与51Cr-EDTA清除率的相关性并不优于血清肌酐,也不能更早诊断肾功能不全。内生肌酐清除率高估GFR 0-180%。由于残余尿量,糖尿病患者的变异系数高于对照组,但采用多个收集期可减少这种不足的影响。总之,发现51Cr-EDTA的肾脏清除率优于其他方法。